Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1–dependent mechanism that is up-regulated by interleukin-13
Top Cited Papers
Open Access
- 16 December 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (25) , 5738-5747
- https://doi.org/10.1182/blood-2010-06-287839
Abstract
Myeloid-derived suppressor cells (MDSCs) are a well-defined population of cells that accumulate in the tissue of tumor-bearing animals and are knownKeywords
This publication has 32 references indexed in Scilit:
- Pegylated arginase I: a potential therapeutic approach in T-ALLBlood, 2010
- Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of alloprimingBlood, 2009
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsProceedings of the National Academy of Sciences, 2009
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activityBlood, 2008
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJournal of Clinical Investigation, 2007
- l-arginine availability regulates T-lymphocyte cell-cycle progressionBlood, 2006
- Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cellsJournal of Clinical Investigation, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Regulation of T Cell Receptor CD3ζ Chain Expression byl-ArginineJournal of Biological Chemistry, 2002
- The formation of peroxynitrite in vivo from nitric oxide and superoxideChemico-Biological Interactions, 1995